Sean T. Moriarty - Mar 4, 2024 Form 4 Insider Report for STEPAN CO (SCL)

Role
VP & GM Surfactants
Signature
/s/ Stephanie J. Pacitti, Attorney-in-Fact for Sean T. Moriarty
Stock symbol
SCL
Transactions as of
Mar 4, 2024
Transactions value $
$0
Form type
4
Date filed
3/6/2024, 06:21 PM
Previous filing
Feb 27, 2024
Next filing
Mar 11, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SCL Performance Shares Award $0 +3.43K $0.00 3.43K Mar 4, 2024 Common Stock 3.43K Direct F1, F2
transaction SCL Restricted Stock Units Award $0 +1.71K $0.00 1.71K Mar 4, 2024 Restricted Stock Units 1.71K Direct F3, F4
transaction SCL Stock Appreciation Right Award $0 +4.69K $0.00 4.69K Mar 4, 2024 Common Stock 4.69K $87.50 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance share represents a contingent right to receive one share of Stepan Company common stock.
F2 The performance shares vest upon the certification of Stepan Company achieving certain performance goals for the performance period ending December 31, 2026.
F3 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Stepan Company common stock.
F4 Vests ratably over three years beginning on the date shown.